Electrocardiography score based on the Minnesota code classification system predicts cardiovascular mortality in an asymptomatic low-risk population

Autor: Wook-Dong Kim, Yonggu Lee, Byung Sik Kim, Hyun-Jin Kim, Jeong-Hun Shin, Jin-Kyu Park, Hwan-Cheol Park, Young-Hyo Lim, Jinho Shin

Publikováno v: Annals of Medicine, Vol 55, Iss 2 (2023)

AbstractBackground The use of a single abnormal finding on electrocardiography (ECG) is not recommended for stratifying the risk of cardiovascular (CV) events in low-risk general populations because of its low discriminative power. However, the value

Externí odkaz: https://doaj.org/article/c5dff7a8f7474271abe24f2da8744f95

A COVID-19 mathematical model of at-risk populations with non-pharmaceutical preventive measures: The case of Brazil and South Africa

Autor: Reuben Asempapa, Bismark Oduro, Ofosuhene O. Apenteng, Vusi M. Magagula

Publikováno v: Infectious Disease Modelling, Vol 7, Iss 1, Pp 45-61 (2022)

This work examines a mathematical model of COVID-19 among two subgroups: low-risk and high-risk populations with two preventive measures; non-pharmaceutical interventions including wearing masks, maintaining social distance, and washing hands regular

Externí odkaz: https://doaj.org/article/aca3b8a6ae904ad4808b08facd98334e

A COVID-19 mathematical model of at-risk populations with non-pharmaceutical preventive measures: The case of Brazil and South Africa

Autor: Vusi Mpendulo Magagula, Ofosuhene O. Apenteng, Bismark Oduro, Reuben Asempapa

Publikováno v: Infectious Disease Modelling, Vol 7, Iss 1, Pp 45-61 (2022)
Asempapa, R, Oduro, B, Apenteng, O O & Magagula, V M 2022, ' A COVID-19 mathematical model of at-risk populations with non-pharmaceutical preventive measures : The case of Brazil and South Africa ', Infectious Disease Modelling, vol. 7, no. 1, pp. 45-61 . https://doi.org/10.1016/j.idm.2021.11.005
Infectious Disease Modelling

This work examines a mathematical model of COVID-19 among two subgroups: low-risk and high-risk populations with two preventive measures; non-pharmaceutical interventions including wearing masks, maintaining social distance, and washing hands regular

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::752ca09259b5c36a1c175f294be2f0f8
http://www.sciencedirect.com/science/article/pii/S2468042721000804

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)

Autor: Susan Baird, Fanny Bajolle, Sebastian Grunt, Olga Lvova, Anthonie W. A. Lensing, Mayte Sánchez van Kammen, William T. Smith, Paolo Simioni, Madhurima Majumder, Christoph Male, Jeanette Payne, Tina T. Biss, Michelle Morales Soto, Veerle Labarque, Elizabeth Chalmers, Joseph Palumbo, Jonathan M. Coutinho, Damien Bonnet, Amparo Santamaría, Riten Kumar, An Van Damme, Ida Martinelli, Kamar Godder, Sanjay J. Shah, Paul Monagle, Paola Saracco, Dagmar Kubitza, Philip Connor, Martin H. Prins, Rukhmi Bhat, Krisztián Kállay, Akos F. Pap, Scott D. Berkowitz, Kerry Hege, Jayashree Motwani, Helene L. Hooimeijer

Publikováno v: Blood advances, 4(24), 6250-6258. The American Society of Hematology
Blood Advances
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Blood advances, 4(24), 6250-6258. American Society of Hematology
Blood Adv.
Blood Adv

Anticoagulant treatment of pediatric cerebral venous thrombosis has not been evaluated in randomized trials. We evaluated the safety and efficacy of rivaroxaban and standard anticoagulants in the predefined subgroup of children with cerebral venous t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be998519446ecd55ada264f5dbeff705
https://doi.org/10.1182/bloodadvances.2020003244

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.